Jane Street Group, LLC Aptinyx Inc. Transaction History

Jane Street Group, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.23 - $0.34 $628 - $928	-2,732 Reduced 2.58%	103,039 $29,000
Q3 2022 Nov 14, 2022	BUY	$0.35 - $0.72 $25,202 - $51,844	72,006 Added 213.26%	105,771 $39,000
Q2 2022 Aug 16, 2022	SELL	$0.38 - $2.58 $1,658 - $11,259	-4,364 Reduced 11.45%	33,765 $19,000
Q1 2022 May 17, 2022	BUY	$2.27 - $3.62 $39,734 - $63,364	17,504 Added 84.87%	38,129 $87,000
Q4 2021 Feb 15, 2022	BUY	$2.11 - $3.0 $43,518 - $61,875	20,625 New	20,625 $55,000
Q3 2021 Nov 16, 2021	SELL	$2.21 - $2.89 $32,909 - $43,034	-14,891 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.39 - $3.5 $9,870 - $14,455	4,130 Added 38.38%	14,891 $42,000
Q1 2021 May 18, 2021	BUY	$2.86 - $4.33 $30,776 - $46,595	10,761 New	10,761 $32,000
Q3 2020 Nov 17, 2020	SELL	$3.05 - $4.99 $154,034 - $252,009	-50,503 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$1.99 - $4.4 $31,838 - $70,395	15,999 Added 46.37%	50,503 $210,000
Q1 2020 May 15, 2020	BUY	$1.81 - $5.03 $62,452 - $173,555	34,504 New	34,504 $75,000
Q4 2019 Feb 14, 2020	SELL	$2.84 - $4.25 $42,909 - $64,213	-15,109 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$3.0 - $4.08 $153,939 - $209,357	-51,313 Reduced 77.25%	15,109 $53,000
Q2 2019 Aug 15, 2019	BUY	$2.95 - $4.38 $195,944 - $290,928	66,422 New	66,422 $222,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.